DEI Stock Analysis: Douglas Emmett | NYSE
REIT - Office | NYSE, USA | Market Cap: 2.507m USD | 12M Return: -14.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 27.0M
Qual. Beats: 0
Rev. Trend: 6.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Douglas Emmett, Inc. (DEI) is a fully integrated, self-administered and self-managed Real Estate Investment Trust (REIT) that owns and operates high-quality office and multifamily properties in the premier coastal submarkets of Los Angeles and Honolulu. The company concentrates on top-tier office assets and premier multifamily communities located in neighborhoods characterized by significant supply constraints, high-end executive housing, and key lifestyle amenities. Incorporated in 1971 and headquartered in Santa Monica, California, DEI trades on the NYSE as a mid-cap stock with a market capitalization of approximately $2.4 billion USD, having gone public in October 2006.
Classified under GICS as a Diversified REIT, Douglas Emmett operates across multiple property types-office and residential-within a single portfolio rather than focusing on a single asset class. As a U.S. REIT, the company is generally required to distribute at least 90% of its taxable income to shareholders in the form of dividends, a structural feature that makes REITs a common holding for income-oriented investors. The strategy of focusing on supply-constrained coastal submarkets reflects an emphasis on scarcity-driven demand and the long-term rental pricing power associated with densely developed, geographically limited urban areas.
- LA office occupancy declines persist amid hybrid work shift
- Honolulu multifamily rents grow on tight supply and tourism demand
- Interest rate cuts ease REIT financing costs and cap rate pressure
| Net Income: -26.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.49 > 1.0 |
| NWC/Revenue: 33.41% < 20% (prev 55.13%; Δ -21.72% < -1%) |
| CFO/TA 0.04 > 3% & CFO 371.2m > Net Income -26.0m |
| Net Debt (5.24b) to EBITDA (601.0m): 8.72 < 3 |
| Current Ratio: 2.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (167.5m) vs 12m ago 0.01% < -2% |
| Gross Margin: 24.21% > 18% (prev 64.07%; Δ -39.86% > 0.5%) |
| Asset Turnover: 10.63% > 50% (prev 10.37%; Δ 0.26% > 0%) |
| Interest Coverage Ratio: 0.75 > 6 (EBIT TTM 202.5m / Interest Expense TTM 271.1m) |
| A: 0.04 (Total Current Assets 552.8m - Total Current Liabilities 217.6m) / Total Assets 9.30b |
| B: -0.17 (Retained Earnings -1.54b / Total Assets 9.30b) |
| C: 0.02 (EBIT TTM 202.5m / Avg Total Assets 9.44b) |
| D: 0.32 (Book Value of Equity 1.87b / Total Liabilities 5.87b) |
| Altman-Z'' = 0.18 = B |
| DSRI: 0.94 (Receivables 195.5m/206.2m, Revenue 1.00b/993.0m) |
| GMI: 2.65 (GM 64.07% / 24.21%) |
| AQI: 1.02 (AQ_t 0.94 / AQ_t-1 0.92) |
| SGI: 1.01 (Revenue 1.00b / 993.0m) |
| TATA: -0.04 (NI -26.0m - CFO 371.2m) / TA 9.30b) |
| Beneish M = -1.57 (Cap -4..+1) = CCC |
As of July 18, 2026, the stock is trading at USD 12.51 with a total of 1,308,980 shares traded. Over the past week, the price has changed by +4.16%, over one month by +10.18%, over three months by +21.67% and over the past year by -14.82%.
Current recommended Stop Loss: 11.90 (which is 4.9% or 1.5 ATR below the current price).
Douglas Emmett has received a consensus analysts rating of 3.31. Therefore, it is recommended to hold DEI.
- StrongBuy: 2
- Buy: 2
- Hold: 7
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 12.9 | 3.1% |
P/E Forward = 9.0009
P/S = 2.499
P/B = 1.0901
P/EG = 11.6749
Revenue TTM = 1.00b USD
EBIT TTM = 202.5m USD
EBITDA TTM = 601.0m USD
Long Term Debt = 5.57b USD (from longTermDebt, last quarter)
Short Term Debt = 1.18b USD (from shortTermDebt, last quarter)
Debt = 5.60b USD (from shortLongTermDebtTotal, last quarter) + Leases 10.8m
Net Debt = 5.24b USD (calculated: Debt 5.60b - CCE 357.2m)
Enterprise Value = 7.75b USD (2.51b + Debt 5.60b - CCE 357.2m)
Interest Coverage Ratio = 0.75 (Ebit TTM 202.5m / Interest Expense TTM 271.1m)
EV/FCF = 69.69x (Enterprise Value 7.75b / FCF TTM 111.2m)
FCF Yield = 1.43% (FCF TTM 111.2m / Enterprise Value 7.75b)
FCF Margin = 11.08% (FCF TTM 111.2m / Revenue TTM 1.00b)
Net Margin = -2.59% (Net Income TTM -26.0m / Revenue TTM 1.00b)
Gross Margin = 24.21% ((Revenue TTM 1.00b - Cost of Revenue TTM 760.5m) / Revenue TTM)
Gross Margin QoQ = -13.90% (prev -16.54%)
Tobins Q-Ratio = 0.83 (Enterprise Value 7.75b / Total Assets 9.30b)
Interest Expense / Debt = 4.85% (Interest Expense 271.1m / Debt 5.60b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 160.0m (EBIT 202.5m * (1 - 21.00%))
Current Ratio = 2.54 (Total Current Assets 552.8m / Total Current Liabilities 217.6m)
Debt / Equity = 2.99 (Debt 5.60b / totalStockholderEquity, last quarter 1.87b)
Debt / EBITDA = 8.72 (Net Debt 5.24b / EBITDA 601.0m)
Debt / FCF = 47.13 (Net Debt 5.24b / FCF TTM 111.2m)
Total Stockholder Equity = 1.93b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.28% (Net Income -26.0m / Total Assets 9.30b)
RoE = -1.35% (Net Income TTM -26.0m / Total Stockholder Equity 1.93b)
RoCE = 2.70% (EBIT 202.5m / Capital Employed (Equity 1.93b + L.T.Debt 5.57b))
RoIC = 1.57% (NOPAT 160.0m / Invested Capital 10.2b)
WACC = 5.32% (E(2.51b)/V(8.10b) * Re(8.65%) + D(5.60b)/V(8.10b) * Rd(4.85%) * (1-Tc(0.21)))
Discount Rate = 8.65% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 66.04 | Cagr: 0.19%
[DCF] Terminal Value 73.10% ; FCFF base≈131.1m ; Y1≈114.9m ; Y5≈92.9m
[DCF] Fair Price = N/A (negative equity: EV 1.49b - Net Debt 5.24b = -3.75b; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.30 | # QB: 0
Revenue Correlation: 6.11 | Revenue CAGR: 0.12% | SUE: 0.11 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.03 | Chg30d=N/A | Revisions=+25% | Analysts=4
EPS next Quarter (2026-09-30): EPS=-0.05 | Chg30d=N/A | Revisions=+25% | Analysts=4
EPS current Year (2026-12-31): EPS=-0.14 | Chg30d=+3.58% | Revisions=+25% | GrowthEPS=-252.8% | GrowthRev=+1.0%
EPS next Year (2027-12-31): EPS=-0.12 | Chg30d=-10.17% | Revisions=+25% | GrowthEPS=+13.3% | GrowthRev=+2.5%
[Analyst] Revisions Ratio: +57% (up=4, down=0)